@article {190, title = {Analysis of Practice of Drug Information Resources by Dentists in Saudi Arabia}, journal = {PTB Reports}, volume = {7}, year = {2021}, month = {April 2021}, pages = {28-34}, type = {Research Article}, chapter = {28}, abstract = {

Aim: This study{\textquoteright}s objective was to analyze dentists{\textquoteright} practice of drug information resources in the Kingdom of Saudi Arabia. Methods: This is a 4-month cross-sectional study about the dentists{\textquoteright} practice of drug information resources in Saudi Arabia. It is a self-reported and electronic survey of dentists. We included dentists from interns to consultants and from all specialties in dentistry and located in Saudi Arabia. The survey consisted of two parts. The first part collected demographic information. The second part collected data about the type of drug information inquiries, aspects of dental drug information resources, and the dental drug information resources and types of dental drug information resources used in practice are responsible. We used the 5-point Likert response scale system to obtain responses to the survey questions. The data were collected through the Survey Monkey system and analyzed through the Statistical Package of Social Sciences (SPSS), Jeffery{\textquoteright}s Amazing Statistics Program (JASP), and Microsoft Excel (version 16). Results: The average number of dental information resources was 0.84 per patient daily. The most commonly referred resource in relation to the dental drug information was biweekly (94 (36.43\%)), monthly (92 (35.66\%)) followed by weekly (35 (13.58\%)) newsletter in addition to those published a few times per year (18 (6.98\%)). The most frequently searched question was about the adverse reaction (190 (73.36\%)) and drug availability (144 (55.60\%)), whereas the majority of the dental prescriptions was related to the oral ulcer (83 (32.05\%)) and sedation medications (74 (28.57\%)). The average score for the item {\textquotedblleft}implemented items for dental drug information resources{\textquotedblright} was 1.78. The highest score was obtained for the element {\textquotedblleft}an annual plan of dental drug information resources{\textquotedblright} (1.88). In contrast, the lowest score was obtained for {\textquotedblleft}dental drug information resources dentist{\textquoteright}s competency{\textquotedblright} (1.7), with statistically significant differences between all responses (p\<0.001). The highest scores of dental drug information resources (to authorities) the responsibility was a clinical pharmacist (4.65) and pharmacy technicians (4.34). In contrast, the lowest score was dentists (2.19), with statistical signification among all answers in each aspect (p\<0.001). Conclusion: Despite the demand for resources to resolve drug-related dental care problems, the resources were seldom utilized. Targeting education and training of dental information resources is required to improve dental patient care in Saudi Arabia.

}, keywords = {Analysis, Dentist, Drug Information, Practice, Resources, Saudi Arabia}, doi = {10.5530/PTB.2021.7.6}, author = {Yousef Ahmed Alomi and Anwar Mouslim Alshammari and Juman saad Mohammad Alsaab} } @article {149, title = {Cost Analysis of Neonatal Drug Distribution Services at Ministry of Health in Saudi Arabia}, journal = {Pharmacology, Toxicology and Biomedical Reports}, volume = {5}, year = {2019}, month = {September 2019}, pages = {S17-S19}, type = {Research Article}, chapter = {S17}, abstract = {

Objectives: The cost estimation of delivery of drug therapy management (unit dose, floor stock and discharge) for neonatal inpatient is a part of the pharmacoeconomic program and changing the system to the Saudi vision 2030 at MOH in Saudi Arabia. The study explored the cost calculations of delivery of drug therapy services for neonate{\textquoteright}s population by using American Model with local cost. Methods: It is cross-sectional 6-months analysis of drug distribution services for neonate patients conducted in 2016. It was at 300-Bed Maternity and Pediatrics Hospital in Riyadh, Saudi Arabia. The cost analysis consisted of three domains. Domain one; the cost of delivery of Adults drug therapy management with 144 beds. Domain two; the cost of delivery of pediatrics drug treatment services with 55 beds. Domain three; cost of delivery for neonate{\textquoteright}s therapy services with 82 beds. For each domain, the physician prescribed the medications. The pharmacist reviewed and prepared drugs and distributed through unit dose system, floor stock distribution and discharge medications. The nurse administered drugs and followed up with doctors. The drugs were prepared through ASHP standards and facilities. The oral and topical ready to deliver drugs were included in the study while sterile product and compounding formulations were excluded from the study. The cost was derived from Ministry of Health information database. The cost model was calculated based on variable expenses including personal cost, material and supply cost. Fixed costs including direct cost, non-salary cost and overhead cost. All cost was used US dollar currency and local prices. This study analyses the three domains. Results: The estimated daily cost of neonatal unit dose drug distribution system for all total pediatrics 82 beds was (1,303.31 US). It contained three types; the unit dose system (794.83 USD), drug floor stock distribution system (371.37 USD) and discharge medication system (137.11 USD). The cost of delivery of medicines to single bed per day was (41.64 USD) with highest estimated cost of delivery from discharge medication (27.42 USD), followed by unit dose services (9.69 USD) and floor stock therapy (4.53 USD). The majority of cost came from overhead cost in floor stock services and discharge medication delivery; while the personal cost in unit dose services delivery. The total estimated annual expenditures of drug distribution services were (475,708.15 USD). Conclusion: The estimated cost of delivery of neonatal medication therapy is a part of the pharmacoeconomic program at pharmacy services and future vision 2030 in Saudi Arabia.

}, keywords = {Analysis, Cost, Distribution, Drug, Ministry of Health, Neonatal, Saudi Arabia, Services}, doi = {10.5530/PTB.2019.5.32}, author = {Yousef Ahmed Alomi and Malika Alhadab and Tahani Alotaibi and Awatif Faraj Alshammari and Nouf Alhaze} }